CD19 and neoplasm: To this end, we used an established human tumour xenograft mouse model, where immunodeficient nod-scid-gamma mice were engrafted subcutaneously with luciferase (LUC)-expressing Raji (CD19+) tumour cells (Raji–RFP–LUC) and either non-engineered donor T cells or donor-derived AEDDMF5 01 T cells.